TargetMol

M 1704

Product Code:
 
TAR-T33105
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T33105-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
M 1704 is a bioactive chemical.
CAS:
36924-82-0
Formula:
C12H14FN5
Molecular Weight:
247.277
Purity:
0.98
SMILES:
CCCc1nc(N)nc(Nc2ccc(F)cc2)n1

References

1. Xiong BL, Zhang JZ, Peng T, Hao Z, Gao Y. [Concentration Variations and Flux Estimation of Dissolved Carbon in Karst Spring of a Typical Karst Area]. Huan Jing Ke Xue. 2018 Nov 8;39(11):4991-4998. doi: 10.13227/j.hjkx.201803118. Chinese. PubMed PMID: 30628221. 2. Shi J, Ye G, Zhao G, Wang X, Ye C, Thammavong K, Xu J, Dong J. Coordinative control of G2/M phase of the cell cycle by non-coding RNAs in hepatocellular carcinoma. PeerJ. 2018 Oct 16;6:e5787. doi: 10.7717/peerj.5787. eCollection 2018. PubMed PMID: 30364632; PubMed Central PMCID: PMC6197396. 3. Koga K, Matsuzaki Y, Migita K, Shimoyama S, Eto F, Nakagawa T, Matsumoto T, Terada K, Mishima K, Furue H, Honda K. Stimulating muscarinic M(1) receptors in the anterior cingulate cortex reduces mechanical hypersensitivity via GABAergic transmission in nerve injury rats. Brain Res. 2019 Feb 1;1704:187-195. doi: 10.1016/j.brainres.2018.10.013. Epub 2018 Oct 17. PubMed PMID: 30339810. 4. Zorzi M, Hassan C, Capodaglio G, Narne E, Turrin A, Baracco M, Dal Cin A, Fiore A, Martin G, Repici A, Rex D, Rugge M. Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study. Ann Intern Med. 2018 Nov 6;169(9):602-609. doi: 10.7326/M18-0855. Epub 2018 Oct 2. PubMed PMID: 30285055.